These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [New inotropic vasodilators: what is their role in the long-term treatment of heart failure?]. Padrini R. G Ital Cardiol; 1987 Mar 15; 17(3):259-63. PubMed ID: 3301506 [No Abstract] [Full Text] [Related]
5. [Treatment of resistant cardiac failure; vasodilators and new inotropic drugs]. Herziano H, Gil I, Almog C. Harefuah; 1980 Jun 15; 98(11-12):517-8. PubMed ID: 7203196 [No Abstract] [Full Text] [Related]
7. Pharmacotherapy of congestive heart failure: pimobendan, a new approach to inotropic stimulation. Proceedings of a satellite symposium to the Xth European Congress of Cardiology. Vienna, Austria, August 31, 1988. J Cardiovasc Pharmacol; 1989 Jun 15; 14 Suppl 2():S1-64. PubMed ID: 2478785 [No Abstract] [Full Text] [Related]
16. [Rational and irrational approach to the inotropic agent therapy of heart failure]. Colombo F, Libretti A. Clin Ter; 1988 Sep 30; 126(6):421-6. PubMed ID: 2974404 [No Abstract] [Full Text] [Related]
17. Vasodilators and inotropic agents in the treatment of congestive heart failure. Francis GS. Semin Nephrol; 1994 Sep 30; 14(5):464-78. PubMed ID: 7997651 [Abstract] [Full Text] [Related]
19. Can new inodilators displace digitalis in the therapy of congestive heart failure? Kumada T, Kawai C. Cardiovasc Drugs Ther; 1989 Jan 30; 2(6):751-5. PubMed ID: 2488088 [Abstract] [Full Text] [Related]